SCHEMBL30067362

SCHEMBL30067362

O=C(Cl)c1cc2c(F)cc(F)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4A3 P38919 2/20 0.47
CNR1 P21554 1/20 0.43
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
HPGD P15428 2/20 0.41
GRIN1 Q05586 2/20 0.41
PDPK1 O15530 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
APEX1 P27695 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
RHEB Q15382 4/20 0.40
IDO1 P14902 3/20 0.36
TDO2 P48775 3/20 0.36
FLT3 P36888 4/20 0.35
MEN1 O00255 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29655546 0.85 EIF4A3 (0.63) EIF4A3CNR1KDM4ELMNAHPGD
SCHEMBL1144892 0.85 EIF4A3 (0.63) EIF4A3CNR1KDM4ELMNAHPGD
SCHEMBL16234661 0.82 EIF4A3 (0.51) EIF4A3CNR1KDM4ELMNAHPGD
SCHEMBL24448445 0.82 EIF4A3 (0.47) EIF4A3CNR1KDM4ELMNAHPGD
SCHEMBL30147573 0.82 EIF4A3 (0.47) EIF4A3CNR1KDM4ELMNAHPGD
SCHEMBL4276853 0.78 ULK1 (0.49) EIF4A3CNR1KDM4ELMNAHPGD
SCHEMBL29897794 0.78 ULK1 (0.49) EIF4A3CNR1KDM4ELMNAHPGD
SCHEMBL18183345 0.78 CNR1 (0.48) EIF4A3CNR1KDM4ELMNAHPGD
SCHEMBL25474874 0.77 EIF4A3 (0.47) EIF4A3CNR1KDM4ELMNAHPGD
SCHEMBL30536689 0.76 EIF4A3 (0.49) EIF4A3CNR1KDM4ELMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119638737-A Macrocyclic compounds and their use in medicine 广东东阳光药业股份有限公司 2025-03-18 CN disclosed
WO-2022240541-A1 NOVEL MACROCYCLIC SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS ENANTA PHARMACEUTICALS, INC. (US) 2022-11-17 WO disclosed